Albireo Pharma Free Cash Flow 2010-2022 | ALBO
Albireo Pharma free cash flow from 2010 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Albireo Pharma Annual Free Cash Flow |
| 2021 |
-108.02 |
| 2020 |
-101.11 |
| 2019 |
-53.46 |
| 2018 |
-26.85 |
| 2017 |
-23.26 |
| 2016 |
-8.79 |
| 2016 |
-12.14 |
| 2015 |
-18.20 |
| 2014 |
-18.77 |
| 2013 |
-18.67 |
| 2012 |
-16.76 |
| 2011 |
-18.44 |
| 2010 |
-34.67 |
| 2009 |
-35.90 |
| Albireo Pharma Quarterly Free Cash Flow |
| 2022-09-30 |
-102.39 |
| 2022-06-30 |
-72.72 |
| 2022-03-31 |
-35.64 |
| 2021-12-31 |
-108.02 |
| 2021-09-30 |
-94.13 |
| 2021-06-30 |
-66.46 |
| 2021-03-31 |
-34.72 |
| 2020-12-31 |
-101.11 |
| 2020-09-30 |
-72.91 |
| 2020-06-30 |
-46.94 |
| 2020-03-31 |
-23.80 |
| 2019-12-31 |
-53.46 |
| 2019-09-30 |
-41.04 |
| 2019-06-30 |
-26.92 |
| 2019-03-31 |
-13.52 |
| 2018-12-31 |
-26.85 |
| 2018-09-30 |
-16.85 |
| 2018-06-30 |
-6.58 |
| 2018-03-31 |
1.05 |
| 2017-12-31 |
-23.26 |
| 2017-09-30 |
-19.81 |
| 2017-06-30 |
-14.57 |
| 2017-03-31 |
-8.62 |
| 2016-12-31 |
-8.79 |
| 2016-09-30 |
-2.33 |
| 2016-06-30 |
1.59 |
| 2016-03-31 |
-2.34 |
| 2015-12-31 |
-3.89 |
| 2015-09-30 |
|
| 2015-06-30 |
-14.69 |
| 2015-03-31 |
-9.01 |
| 2014-12-31 |
-5.44 |
| 2014-09-30 |
|
| 2014-06-30 |
-15.31 |
| 2014-03-31 |
-11.15 |
| 2013-12-31 |
-4.55 |
| 2013-09-30 |
|
| 2013-06-30 |
-15.06 |
| 2013-03-31 |
-11.16 |
| 2012-12-31 |
-4.78 |
| 2012-09-30 |
|
| 2012-06-30 |
-11.26 |
| 2012-03-31 |
-7.38 |
| 2011-12-31 |
-3.67 |
| 2011-09-30 |
|
| 2011-06-30 |
-15.09 |
| 2011-03-31 |
-11.51 |
| 2010-12-31 |
-6.69 |
| 2010-09-30 |
|
| 2010-06-30 |
-31.15 |
| 2010-03-31 |
-22.09 |
| 2009-12-31 |
-15.24 |
| 2009-09-30 |
|
| 2009-06-30 |
-25.96 |
| 2009-03-31 |
-18.34 |
